A randomized, double-blind, clinical trial comparing the efficacy and safety of Crocus sativus L. with fluoxetine for improving mild to moderate depression in post percutaneous coronary intervention patients
Nazila Shahmansouri(Tehran University of Medical Sciences), Shahin Akhondzadeh(Arak University of Medical Sciences), Amirhossein Gougol(Tehran University of Medical Sciences), Saeedeh Forghani(Razi Vaccine and Serum Research Institute), Sepideh Saroukhani(Tehran University of Medical Sciences), Habibeh Yekehtaz(Arak University of Medical Sciences), Akram Arjmandi-Beglar(Tehran University of Medical Sciences), Mehdi Farokhnia(National Institutes of Health), Seyed Ebrahim Kassaian(Tehran University of Medical Sciences), Ahmad-Ali Noorbala Tafti(Roozbeh Hospital), Mehran Mahmoodian(Tehran University of Medical Sciences), Seyed-Hesammeddin Abbasi(Iran University of Medical Sciences)
Cited by 135
Related Papers
The glucagon-like peptide-1 (GLP-1) analogue semaglutide reduces alcohol drinking and modulates central GABA neurotransmission
|JCI Insight|2023|200
Sex Differences in Opioid and Psychostimulant Craving and Relapse: A Critical Review
|Pharmacological Reviews|2022|155
N-Acetylcysteine as an Adjunct to Risperidone for Treatment of Negative Symptoms in Patients With Chronic Schizophrenia
|Clinical Neuropharmacology|2013|154
Comparing the efficacy and safety of<i>Crocus sativus</i>L. with memantine in patients with moderate to severe Alzheimer's disease: a double-blind randomized clinical trial
|Human Psychopharmacology Clinical and Experimental|2014|151
Education Attainment and Alcohol Binge Drinking: Diminished Returns of Hispanics in Los Angeles
|Behavioral Sciences|2019|131